| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/10/2004 | EP1395305A1 Using supercritical fluids to infuse therapeutic on a medical device |
| 03/10/2004 | EP1395290A2 Cytotoxic cd44 antibody immunoconjugates |
| 03/10/2004 | EP1395286A2 Pharmaceutical combination comprising an anti-androgen and an oestrogen receptor beta agonist |
| 03/10/2004 | EP1395279A2 Use of neublastin polypeptides for treating neuropathic pain |
| 03/10/2004 | EP1395274A2 Compositions and methods for inhibiting metastasis |
| 03/10/2004 | EP1395270A1 Use of phyllanthus constituents for treating or preventing infections caused by hepatit |
| 03/10/2004 | EP1395262A2 Nucleoside vaccine adjuvants |
| 03/10/2004 | EP1395259A2 Urazole compounds useful as anti-inflammatory agents |
| 03/10/2004 | EP1395256A2 Prodrugs via acylation with cinnamate |
| 03/10/2004 | EP1395255A2 Cddo-compounds and combination therapies thereof |
| 03/10/2004 | EP1395244A1 Oxidized collagen formulations for use with non-compatible pharmaceutical agents |
| 03/10/2004 | EP1234043B1 Constructs for delivery of therapeutic agents to neuronal cells |
| 03/10/2004 | EP1163244B1 Thienopyrimidine compounds, their production and use |
| 03/10/2004 | EP1140942B1 Prenyl transferase inhibitors |
| 03/10/2004 | EP1084120B1 Cinnamoyl distamycin analogous derivatives, process for their preparation, and their use as antitumor agents |
| 03/10/2004 | EP0868198B1 FCepsilon-PE CHIMERIC PROTEIN FOR TARGETED TREATMENT OF ALLERGY RESPONSES, A METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| 03/10/2004 | EP0651653B1 p53 VACCINE |
| 03/10/2004 | CN1481390A Immunomodulatory peptidesderived from heat shock proteins and uses thereof |
| 03/10/2004 | CN1481377A Cyclic Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF alhpa |
| 03/10/2004 | CN1481370A Quinazoline derivatives, medicaments contg. said compounds, their utilization and method for prodn. thereof |
| 03/10/2004 | CN1481367A Imidazole and benzimiddzole caspase inhibitors and uses thereof |
| 03/10/2004 | CN1481366A Dihydroindole and tetrahydroquinoline derivatives |
| 03/10/2004 | CN1481364A Urea and urethane derivatives as integrin inhibitors |
| 03/10/2004 | CN1481358A Carboxylic acid amide derivatives and their use in treatment of thromboembolic diseases and tumours |
| 03/10/2004 | CN1481255A Vaccines |
| 03/10/2004 | CN1481253A Drugs and foods improving quality of life and process for producng same |
| 03/10/2004 | CN1481247A Use of zolendronate for mfg. medicament for treatment of bone metabolism diseases |
| 03/10/2004 | CN1481244A Pharmaceutical formulation contg pyrazolo [4,3-D] pyrinidines, calcium antagonists, prostaglandins or prostaglandin derivatives |
| 03/10/2004 | CN1481243A Pharmaceutical formulation contg. thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2) |
| 03/10/2004 | CN1481242A Pharmaceutical formulation contg thienopyrimidines and antithrombotics, calcium-antagonists, prostaglandins or prostaglandin derivatives |
| 03/10/2004 | CN1481237A Method for producing organic solvent-free lycopene concentrate, resulting concentrate and compsn comprising said concentrate |
| 03/10/2004 | CN1480465A Recombinded chemotaxis cytokine of human cirumferential lymphatic tissue as well as its preparing method and usage |
| 03/10/2004 | CN1480463A Chirality peptide antigen and compon of bacterin based on core sequence of mucin 1 |
| 03/10/2004 | CN1480454A Antagon of endostadin receptor pyrazole carboxylic acids |
| 03/10/2004 | CN1480214A Vaccinum contg saponin and sterol |
| 03/10/2004 | CN1480211A Usage of gene NMESI related to esophageal carcinoma and encoded polypeptide |
| 03/10/2004 | CN1480209A Method for producing compound preparation of propolis |
| 03/10/2004 | CN1480207A Spore of gandoderma lucidum for treating disease of autoimmunity |
| 03/10/2004 | CN1480202A Propolis drop pills and its preparing method |
| 03/10/2004 | CN1480192A Medication for treating cancer and chronic hepatitis B and its prepn. method |
| 03/10/2004 | CN1480178A Combination of medication for anti herpes virus and its application |
| 03/10/2004 | CN1480168A Chinese herbal medicine for preventing |
| 03/10/2004 | CN1480167A Chinese herbal medicine for preventing cancer |
| 03/10/2004 | CN1480156A Chinese herbal medicine for anti-cancer and its prepn method |
| 03/10/2004 | CN1480137A Osmotic pump type controlled release preparation of kurarinone and its preparing method |
| 03/10/2004 | CN1480134A Combination of iodine amino acid as well as its preparation method and application |
| 03/10/2004 | CN1141315C Three-chain formed oligonucleotide capable of inhibiting platelet derived growth factor gene expression and its application |
| 03/10/2004 | CN1141314C 2',3'-O-isopropylidennucleoside 5'-thiophosphamino acid ester compound |
| 03/10/2004 | CN1141295C Indoline derivatives as progesterohe antagonists |
| 03/10/2004 | CN1141292C Cytostatic agents |
| 03/10/2004 | CN1141146C Pure beta ray carrying safe microball and its preparation |
| 03/10/2004 | CN1141142C Genetically engineered vaccine of MUC-1 antigen for human breast cancer |
| 03/10/2004 | CN1141141C Achyranthis bidentatae glycopeptide and its preparation |
| 03/10/2004 | CN1141139C Anti-cancer medicine and its peparation method |
| 03/10/2004 | CN1141137C Chinese medicine injection for stopping cancer pain |
| 03/10/2004 | CN1141126C Chinese medicine compsn for treating cancer |
| 03/10/2004 | CN1141110C Capsule for treating cancer and its prepn method |
| 03/10/2004 | CN1141109C Chinese patent medicine for curing acute leukemia and its preparation process |
| 03/10/2004 | CN1141106C South-China osmunda japonica tea and its preparation method |
| 03/10/2004 | CN1141103C Bcl-2 gene antisense nucleic acid medicine for resisting leukemia and tumor drug-fast |
| 03/10/2004 | CN1141095C Preparation containing combination of N-5-methylisoxazole-4-carboxylic acid-(4-trifluoromethy1)-anilid and N-(4 trifluoromethylphenyl)-2-cyano-3-hyroxycrotonic acid amide |
| 03/10/2004 | CN1141093C Anticancer lichee lectone medicine and its prepn |
| 03/10/2004 | CN1141092C Composition for preventing and treating osteoporosis and cancer and decreasing decreasing blood fat and its application |
| 03/10/2004 | CN1141087C Release-controlling coating of antineoplastic lomustine for preventing tumour |
| 03/10/2004 | CN1141083C Preparing process and application of clam lipoid |
| 03/09/2004 | US6703422 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; alzheimer's disease; syndrome x; peroxisome proliferator activated receptor-associated disorder |
| 03/09/2004 | US6703417 Improved bioavailability; anticarcinogenic |
| 03/09/2004 | US6703415 Epoxides or thiirane derivatives; treating or preventing cancer, angiogenesis, arthritis, connective tissue disease, cardiovascular disease, inflammation or autoimmune disease; antifertility agents |
| 03/09/2004 | US6703413 Production of apoptotic films for direct contact with tumors |
| 03/09/2004 | US6703411 Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/09/2004 | US6703402 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
| 03/09/2004 | US6703399 Halo-alkyl esters of camptothecins and methods of treating cancer using these compounds |
| 03/09/2004 | US6703387 Inhibitors of HPV E1 helicase enzyme |
| 03/09/2004 | US6703382 Promoting apoptosis by administering compounds such as 2,9-dimethoxy-11,12-dihydrodibenzo(c,g)(1,2)diazocine-5,6-dioxide; anticancer agents |
| 03/09/2004 | US6703380 Prevention of cancer |
| 03/09/2004 | US6703232 Contacting human embryo kidney 293 (hek 293) cells with at least two different reoviruses to infect; incubation to reassort; harvesting |
| 03/09/2004 | US6703225 Having high specific activity, and a gene thereof, as well as medical uses; eg. for hepatitis and cancer |
| 03/09/2004 | US6703049 Angiogenesis inhibitor |
| 03/09/2004 | US6703046 Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use |
| 03/09/2004 | US6703016 Apoptotic bodies, monocyte derived cells containing the same, a process for their preparation and their uses as vaccines |
| 03/09/2004 | CA2323929C Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
| 03/09/2004 | CA2260016C Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 03/05/2004 | CA2439440A1 Treatment of tuberous sclerosis associated neoplasms |
| 03/05/2004 | CA2437690A1 Ganoderma lucidum spores for treatment of autoimmune diseases |
| 03/04/2004 | WO2004018999A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 03/04/2004 | WO2004018684A2 T-cell epitopes in staphylococcal enterotoxin b |
| 03/04/2004 | WO2004018681A2 Il-7 drug substance, il- 7 comprising composition, preparation and uses thereof |
| 03/04/2004 | WO2004018680A1 Method of screening tumor antigen |
| 03/04/2004 | WO2004018678A1 Preventives/remedies for cancer |
| 03/04/2004 | WO2004018667A1 Peptides and drugs containing the same |
| 03/04/2004 | WO2004018659A1 Process for the production of temperature-induced tumor cell lysates for use as immunogenic compounds |
| 03/04/2004 | WO2004018648A2 Methods for treating patients and identifying therapeutics |
| 03/04/2004 | WO2004018619A2 P53 binding t cell receptor molecules and uses thereof |
| 03/04/2004 | WO2004018598A1 Fat composition |
| 03/04/2004 | WO2004018510A1 Marker for cancer |
| 03/04/2004 | WO2004018496A1 Inhibitors of nucleoside phosphorylases and nucleosidases |
| 03/04/2004 | WO2004018481A2 Gossypol derivatives, production methods thereof and uses of same |
| 03/04/2004 | WO2004018479A1 Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone |
| 03/04/2004 | WO2004018475A2 Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents |
| 03/04/2004 | WO2004018473A2 Azapurine derivatives |